Success Stories: A Chemist from India Earns EB-1A Approval despite RFE
Client’s Testimonial:
“Thank You Very Much For Your Continuous Efforts And Help”
On September 9th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Quality Control Chemist in the Field of Chemical Sciences (Approval Notice).
General Field: Chemical Sciences
Position at the Time of Case Filing: Quality Control Chemist
Country of Origin: India
State of Residence at the Time of Filing: Florida
Approval Notice Date: September 9th, 2025
Processing Time: 18 months, 13 days
Case Summary:
North America Immigration Law Group (NAILG) is delighted to announce the approval of an EB-1A (Alien of Extraordinary Ability) petition for a quality control chemist from India specializing in chemical sciences. At the time of filing, the client was employed as a quality control chemist in the pharmaceutical sector, where he applied advanced chemical techniques to ensure drug quality and safety. After carefully presenting his record of impactful research and professional service, we filed his petition, which was approved in 18 months and 13 days. With our help, the client secured success despite receiving an RFE.
Proposed Endeavor: Advancing Chemical Sciences for Drug Development and Human Health
The client’s proposed endeavor focuses on conducting innovative research in chemical sciences to improve synthetic methodologies, catalysis, and medicinal chemistry applications. His work provides a foundation for developing new therapeutic agents, advancing drug design, and contributing to public health. With applications ranging from cardiovascular disease treatment to wastewater remediation and nanomaterials, his research directly supports the United States’ priorities in healthcare, environmental sustainability, and pharmaceutical innovation.
Notable Achievements Supporting the Petition NAILG emphasized the following accomplishments to demonstrate his eligibility:
- Education and Training: Holds a Ph.D. in chemistry with expertise spanning synthetic chemistry, medicinal chemistry, and catalysis.
- Publications: Authored 27 peer-reviewed journal articles (5 first-authored), published in selective venues in chemistry and pharmaceutical sciences.
- Citations: His work has been cited 567 times, placing him in the top 1% of most-cited researchers in chemistry over the past decade. Several of his articles rank among the top 10% most-cited works in the field.
- Peer Review Service: Conducted at least 61 reviews for respected journals, including those ranked among the top in medicinal and organic chemistry, reflecting his recognized expertise. He also serves on editorial boards, underscoring his influence in maintaining research standards.
- Global Recognition: His work has been cited by researchers in more than 44 countries across six continents, proving its broad international influence.
The client received six recommendation letters. A supporting expert letter described his impact on drug development as follows:
“Based on [The Client]'s outstanding research achievements in the past, I believe that he will continue to contribute greatly to his field and the United States scientific community.”
EB-1A Approval and OutlookThe approval of this EB-1A petition affirms the significance of the client’s contributions and his potential for continued impact in chemical sciences. NAILG is proud to have represented this accomplished researcher. His ongoing work will strengthen drug development, support pharmaceutical safety, and advance chemical innovations critical to the United States’ scientific and public health interests.